Alnylam Pharmaceuticals (ALNY)
$253.7 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
4 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Alnylam Pharmaceuticals, AI stock picks, stock alerts and much more.
ALNY AI Stock Analysis
AI stock analysis for ALNY is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Alnylam Pharmaceuticals (ALNY) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ALNY Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Alnylam Pharmaceuticals (ALNY), currently trading at $253.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALNY
-
Alnylam Pharmaceuticals, Inc.
-
Symbol
ALNY
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
32.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.34 1.9% |
6 |
 |
Inovio Pharmaceuticals INO |
$4.19 4.5% |
2 |
 |
Moderna MRNA |
$43.39 3.2% |
4 |
 |
Anavex Life Sciences AVXL |
$9.03 0.1% |
4 |
 |
BridgeBio Pharma BBIO |
$27.49 4% |
5 |
News
ALNY Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
ALNY Financials
ALNY Key Metrics
-
Total Revenue
$420.1M
-
Net Income
-$111.6M
-
Earnings per Share
-$0.87
-
Free cash flow
$39.5M
-
EBITDA
-$76.9M
-
EBITDA Ratio
-0.183044
-
Total Assets
$4.2B
ALNY 2-year Revenue & Income
ALNY 2-year Free Cash Flow
ALNY Technicals
ALNY SMA
ALNY RSI
FAQ
What's the current price of Alnylam Pharmaceuticals (ALNY) Stock?
The price of an Alnylam Pharmaceuticals (ALNY) share is $253.7.
What's the market cap of Alnylam Pharmaceuticals?
The current market cap of Alnylam Pharmaceuticals is 32.7B.
Should I buy or sell ALNY?
Alnylam Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Alnylam Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Alnylam Pharmaceuticals a good investment?
The current analysis of Alnylam Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Alnylam Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Alnylam Pharmaceuticals (ALNY) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Alnylam Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Alnylam Pharmaceuticals (ALNY) that investors often compare it to?
Alnylam Pharmaceuticals (ALNY) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Alnylam Pharmaceuticals' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Alnylam Pharmaceuticals' stock price to be around $268.5 in 2025. Starting from the current price of $253.7, this represents a 5.8% change in price, indicating a bullish outlook for the stock.
How to buy Alnylam Pharmaceuticals (ALNY) Stock?
Alnylam Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Alnylam Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.